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A B S T R A C T   
Maintenance of the endothelial blood-brain-barrier (BBB) through Wnt/β-catenin signalling is essential for 
neuronal function. The cells however, providing Wnt growth factors at the adult neurovascular unit (NVU) are 
poorly explored. Here we show by conditionally knocking out the evenness interrupted (Evi) gene in astrocytes 
(EviΔAC) that astrocytic Wnt release is crucial for BBB and NVU integrity. EviΔAC mice developed brain oedema 
and increased vascular tracer leakage. While brain vascularization and endothelial junctions were not altered in 
10 and 40 week-old mice, endothelial caveolin(Cav)-1-mediated vesicle formation was increased in vivo and in 
vitro. Moreover, astrocytic end-feet were swollen, and aquaporin-4 distribution was disturbed, coinciding with 
decreased astrocytic Wnt activity. Vascular permeability correlated with increased neuronal activation by c-fos 
staining, indicative of altered neuronal function. Astrocyte-derived Wnts thus serve to maintain Wnt/β-catenin 
activity in endothelia and in astrocytes, thereby controlling Cav-1 expression, vesicular abundance, and end-feet 
integrity at the NVU.   
1. Introduction 
Since the establishment of the blood-brain barrier (BBB) concept by 
Max Lewandowsky (1900) and after coining the “BBB” term by Lina 
Stern and Raymond Gautier (1922) (reviewed by (Saunders et al., 
2014)), astrocytes (ACs) at the neurovascular unit (NVU) have been 
considered as a major source of barrier-promoting factors (Cheslow and 
Alvarez, 2016; Liebner et al., 2011). In the last decade, the molecular 
structure of the BBB has been explored in great detail, and specifically 
the canonical Wnt/β-catenin pathway, mainly driven by Wnt7a, Wnt7b 
and the non-Wnt-related ligand norrin (Ndp), were shown to regulate 
angiogenesis as well as barriergenesis during development (Daneman 
et al., 2009; Liebner et al., 2008; Posokhova et al., 2015; Stenman et al., 
2008; Vanhollebeke et al., 2015; Zhou and Nathans, 2014; Zhou et al., 
2014a). It has been shown that during vertebrate embryonic develop-
ment, Wnt factors are primarily secreted by neural precursor cells, 
fostering vessel growth and barrier formation (Daneman et al., 2009; 
Weidenfeller et al., 2007). Although vessels throughout the central 
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nervous system (CNS) develop barrier characteristics, with exception of 
the choroid plexus (CP), the circumventricular organs (CVOs) and to 
some extent the subventricular zone (SVZ), their properties and the 
molecular endowment was shown to be highly site-specific within the 
CNS (Benz et al., 2019; Saubaméa et al., 2012; Wang et al., 2010). With 
regard to the Wnt/β-catenin pathway, the retina, the olfactory bulb and 
the cerebellum utilize Ndp as the major ligand driving β-catenin sig-
nalling via a receptor complex formed by frizzled 4 (Fzd4), low-density 
lipoprotein receptor-related protein 5 (Lrp5), and tetraspannin 12 
(Tspan12) (Chang et al., 2017; Eubelen et al., 2018; Vallon et al., 2018). 
In the developing CNS, neural precursor cells are considered the 
major source of Wnt pathway-activating factors and blood vessels were 
shown to acquire, yet premature, BBB properties by ~E15 (Daneman 
et al., 2009; Lippmann et al., 2011; Stenman et al., 2008; Weidenfeller 
et al., 2007). Radial glia, which are present at the time point of neuro-
ectodermal angiogenesis, have crucial function in angiogenic processes 
by secreting pro-angiogenic factors like VEGF and CXCL4 as well as the 
barrier-promoting factor retinoic acid (Cheslow and Alvarez, 2016). 
However, they appear to inhibit Wnt pathway activation in ECs, sug-
gesting that they have functions other than secreting Wnt factors (Ma 
et al., 2013). Although the recent reports strongly suggest that BBB in-
duction takes place far before astrocyte differentiation, it has also been 
shown that the maintenance of BBB function requires continuous 
β-catenin transcriptional activity (Zhou et al., 2014b). 
Although more recently pericytes (PCs) have been shown to promote 
barrier properties in ECs in vivo and in vitro, for decades, ACs have been 
the prime suspects to secrete factors relevant for BBB maintenance 
(Haseloff et al., 2005; Janzer and Raff, 1987). Interestingly, as recently 
shown by Vanlandewijck as well as by Zhang and colleagues, pericytes 
do not express Wnt7a/Wnt7b whereas ACs appear to be the CNS cell 
type predominantly expressing these barrier-relevant growth factors in 
the adult mouse brain (Vanlandewijck et al., 2018; Zhang et al., 2014). 
Nonetheless, formal proof on the nature and function of these 
barrier-inducing factors is still missing. Specifically, since identification 
of the Wnt/β-catenin pathway as the key driver of barrier formation, it 
has not systematically been explored, which Wnt factors are released by 
ACs and if they contribute to BBB maintenance in vivo. 
In order to tackle this question, we have conditionally deleted the 
Wnt secretion mediator wntless (Wls), also known as evenness interrupted 
(Evi) or Gpr177, in ACs (Bänziger et al., 2006). Cre recombinase 
expression was driven under the constitutively active human glial 
fibrillary acidic protein (hGFAP) promoter, leading to the deletion of the 
floxed Evi gene (Bajenaru et al., 2002; Carpenter et al., 2010). 
Here we show that mice harbouring the conditional Evi deletion 
(EviΔAC) are alive, viable and born in the expected mendelian ratio, 
showing no gross morphological and behavioural phenotype compared 
to littermate controls (EviCtrl). We did not observe significant changes in 
vessel morphology regarding vessel density and branching as well as 
extracellular matrix (ECM) distribution, despite decreased expression of 
Wnt pathway target genes in ECs. However, EviΔAC exhibit a mild brain 
oedema and increased fluorescent tracer extravasation at 10 and 40 
weeks of age, partially correlating with downregulation of junction 
genes like VE-cadherin/Cdh5 and zonula occludens-1/Tjp1 at 40 weeks, 
whereas junction morphology and function was unaffected. Instead, the 
frequency of endothelial vesicles and caveolin-1 (Cav-1) expression was 
significantly increased in EviΔAC mice. In line with the hampered 
endothelial barrier function, 40-week-old EviΔAC mice showed altered 
coverage of brain capillaries by astrocytic end-feet, evidenced by 
aquaporin-4 (Aqp4) staining. Moreover, electron microscopy revealed 
significant swelling of astrocytic end-feet in EviΔAC mice, suggesting a 
cell-autonomous role of astrocytic Wnt factors via an autocrine pathway. 
2. Material and methods 
2.1. Animals 
Animals were housed under standard conditions and fed ad libitum. 
All experimental protocols, handling and use of mice were approved by 
the Regierungspräsidium Darmstadt, Germany (V54− 19c20/15-FK/ 
1052). The transgenic mouse strains used in the project include hGFAP- 
Cre (Bajenaru et al., 2002), Eviflox/flox (Carpenter et al., 2010) and 
Rosa26mT/mG (The Jackson Laboratory, #007,576) (Muzumdar et al., 
2007). 
2.2. In vivo permeability assessment 
2.2.1. Wet/dry assay 
In order to assess the water content of the CNS tissue in our model, 
we performed a wet/dry experiment (Armulik et al., 2010). After 
anaesthesia (Ketamine 100 mg/kg, Xylazine 10 mg/kg), adult animals 
(10–20 weeks) were transcardially perfused with HBSS 1X during 5 min. 
Tissues were collected in 2 mL Eppendorf tubes and immediately 
weighed. After 6 days at 62 ◦C (open tubes), tissues were weighed again. 
Ratio between wet and dry tissue was calculated, as a well as the ratio of 
wet brain tissue to body weight. Data were compared using the Mann 
and Whitney test. 
2.2.2. Tracer permeability 
A mixture (1:2) of 2 mM Texas Red 3 kD dextran (TXR, #D3328, 
Invitrogen) and 5 mM fluorescein-5-thiosemicarbazide 0.42 kD (FTSC, 
#F121, Molecular Probes) was injected intravenously in anesthetized 
adult animals (10–20 weeks; 100 μl/25 g mouse) and allowed to circu-
late for 5 min as described in Devraj et al. (Devraj et al., 2018). After 
atrial puncture, 200− 300 μL of blood was collected from the chest cavity 
(Micro tube Z-gel, #41.1500.005, Sarstedt) and thereafter, mice were 
immediately transcardially perfused for 3 min with PBS. Brain (cor-
tex/subcortical area and cerebellum without hindbrain), spinal cord, 
liver and kidney as well as serum were collected and stored at − 80 ◦C. 
On the day of fluorescence measurement, samples were thawed on ice, 
weighed and homogenized in PBS (300 μL for cortex, kidney and liver, 
100 μL for spinal cord and cerebellum). Samples were centrifuged for 20 
min, 4 ◦C at 15,000 g, and 40 μL of the supernatant or serum (1:4 
dilution in PBS) were loaded on 384 well plate and fluorescence emis-
sions (relative fluorescence units, RFU) were measured in a microplate 
reader (Tecan Infinite® 200 PRO, Switzerland) at excitation/emission 
wavelength of 595/625 nm for TXR dextran and 490/520 nm for FTSC. 
Sham animals (injection of PBS without tracer) were used to subtract 
auto-fluorescence values from the tissue and serum. Permeability index 
was calculated as follows: Permeability Index (mL/g) = (Tissue RFUs/g 
tissue weight)/(Serum RFUs/mL serum). Data were compared using a 
t-test for each tissue independently. 
For qualitative tracer leakage assessment, Alexa555®-Cadaverin was 
injected intravenously in anesthetized 10- and 40-week-old mice (2.5 
mg/mL, 50 μl/25 g mouse, #A30677, Thermo Fisher Scientific) and 
allowed to circulate for 5 min. To make sure that the same amount of 
tracer was injected in all animals, blood was collected as described 
above and subsequently, mice were transcardially perfused for 3 min 
with PBS. Tissue was fixed in 4% PFA overnight at 4 ◦C and vibratome 
sections were cut thereafter at 50 μm thickness. For blocking and per-
meabilization, the tissue was incubated overnight (10% NDS, 0.1% 
Triton-X100 in PBS). Primary antibodies (Table 1) were incubated for 24 
h and secondary for 4 h in antibody incubation buffer (1% BSA, 0.1% 
Triton-X100 in PBS). Sections were imaged either on a Nikon C1si 
confocal microscope (Nikon Instruments, Inc., Düsseldorf, Germany). 
2.3. Isolation of mouse brain microvessels (MBMVs) 
To investigate possible age-related differences, experiments were 
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performed on both young adult (10 weeks) and middle-aged adult (40 
weeks) mice. After cervical dislocation, brains were isolated and rolled 
on a sterile Whatman filter membrane (Schleicher & Schuell, Germany) 
to peel off meninges. They were subsequently homogenized in MBMV 
buffer (Fisher et al., 2007) using a dounce homogenizer (0.025 mm 
clearance, Wheaton, DWK Life Sciences) and centrifuged at 400 g for 10 
min at 4 ◦C. The pellet was resuspended in 25% BSA and centrifuged at 
2000 g for 20 min to remove myelin fat. The microvessel pellet con-
taining also red blood cells and other single cells was resuspended in 
MBMV buffer and filtered through a 40 μm nylon mesh (#352340, 
Corning). For staining analysis, 5 μL of vessel suspension were deposited 
on fibronectin-precoated slide and fixed with 4% PFA for 5 min. For 
protein analysis, microvessels (from the top of the mesh) were resus-
pended in HES buffer (250mM sucrose, 20mM HEPES pH 7.4, 1 mM 
EDTA) (Devraj et al., 2011) with protease and phosphatase inhibitors 
(#4693159001 and #4906837001, respectively; Merck, Germany), 
sonicated (3 times 5 s, at 10% intensity; Bandelin Nanopuls equipped 
with an MS72 probe, Bandelin electronic GmbH & Co. KG, Germany) 
and stored at − 80 ◦C. For RNA expression analysis, the microvessels 
were lysed in RLTplus buffer (RNeasy Plus Micro kit, #74034, Qiagen, 
Germany) and stored at − 80 ◦C until use. 
2.4. RT and qRT-PCR 
RNA isolation was performed using the RNeasy plus Microkit (Qia-
gen) according to manufacturer’s recommendations. For MBMVs anal-
ysis, 200 ng of RNA were used to generate cDNA (RevertAidTM H minus 
first strand cDNA synthesis kit, #K1632, ThermoScientific). For regular 
cell culture sample and whole brain, 500 ng of RNA were used. 
Reverse Transcriptase PCR (RT-PCR) was performed on cDNA from 
cultured ACs using the Platinum™ Taq DNA polymerase (#11304011, 
Thermofisher) and the primers listed in Supplementary Table 1. Refer-
ence gene was G6pdx and RNA from mouse embryo E14.5 was used as 
positive control of amplification. RT-PCR products were loaded on 1.5% 
agarose gel and pictures were taken with a MultiImage™ Light Cabinet 
(FluorChem, Alpha Innotech/ProteinSimple, USA). 
Quantitative real time RT-PCR (qRT-PCR) was performed using the 
Absolute qPCR SYBR Green Fluorescein Mix (AB-1219, Thermo Scien-
tific) according to manufacturer’s protocol. Reference genes were CD31 
(vessels fragments analysis) or Rplp0. Expression data were analysed 
(CFX96, Biorad) and significance was calculated with GraphPad Prism 
6.0 software using a t-test for all analyses except for the TEER experi-
ments for which a one-way ANOVA followed by a Tukey’s multiple 
comparison test was applied. Primer sequences used for cDNA amplifi-
cation by qRT-PCR are listed in Table 2. 
2.5. Immunohistochemical staining and quantification on cryosections 
and MBMVs 
Post anaesthesia, mice were i.v. injected with tomato lectin-Alexa 
649, and was allowed to circulate for 5 min before sacrificing the ani-
mal. Mice were sacrificed by cervical dislocation and brains were 
collected and frozen in native state in O.C.T. and stored at − 80 ◦C. 
Coronal sections (10 μm, from bregma 0.98 and -1.82 mm) were fixed in 
ice-cold MetOH for 3 min followed by 1 h incubation in 
Table 1 
Antibodies for immunohistochemical staining on MBMVs, cryo- and vibratome sections.  
Antibody Marker for Company Catalog # Dilution Method 
AQP4 AC end-feet EMD Millipore AB 2218 1:200 PFA 
β-galactosidase  Abcam AB616 1:500 PFA 
Caveolin-1 vesicles BD Bioscience #610,059 1:200 MetOH 
CD13/ Amino- 
peptidase N 
PC R&D System AF2335 1:200 PFA 
CD31 EC BD Pharmingen #553,370 1:100 PFA 
Cdh5/VE-cadherin EC junction Santa-Cruz Biotechnology sc-6458 1:100 MetOH 
c-fos (H-125) neuronal activation Santa-Cruz Biotechnology sc-7202 1:1000 PFA 
Cldn5 brain EC junction Thermo Fisher Scientific #341,600 1:200 MetOH 
Collagen IV basal lamina Bio-Rad 2150− 1470 1:400 MetOH 
Desmin PCs Dako M0760 1:200 PFA 
GFAP AC cytoplasm Abcam AB53554 1:500 PFA 
Glut-1 (C-terminal) BBB ECs Ian A Simpson (Devraj et al., 2011) Rb serum 1:300 MetOH 
Lama2 AC ECM Abcam AB11576 1:200 MetOH 
Lama4 EC/PC ECM Lydia Sorokin 377 (Rb serum) 1:1000 MetOH 
Lama5 EC/PC ECM Lydia Sorokin 4G6 A2 11 (R monoclonal) Hybridoma SN, undiluted MetOH 
Podocalyxin (Podxl) luminal EC membrane R & D Systems AF1556, 1:100 PFA/ 
MetOH 
tomato-lectin luminal EC membrane Vector laboratories DL-1178 (Alexa 649) 80 μL/mouse  
Donkey α-goat DyLight 550  Thermo Fisher Scientific SA5− 10087 1:500  
Donkey α-goat DyLight 650  Thermo Fisher Scientific SA5− 10089 1:500  
Donkey α-rabbit DyLight 488  Thermo Fisher Scientific SA5− 10038 1:500  
Donkey α-rabbit DyLight 550  Thermo Fisher Scientific SA5− 10039 1:500  
Donkey α-rat DyLight 550  Thermo Fisher Scientific SA5− 10027 1:500   
Table 2 
Primer sequences used for cDNA amplification by qRT-PCR.  
Primer for Sequence 5′-3′ sense Sequence 5′-3′ antisense 
qmm_Abcb1a/P-gp gctatcacggccaacatctcc tgtccaacactgaatgctccaa 
qmm_Abcg2 tggcatctctggaggagaaaga cgaggctgatgaatggagaaga 
qmm_Axin2 gccgacctcaagtgcaaactc ggctggtgcaaagacatagcc 
qmm_Cav1 gacgcgcacaccaaggagatt ctgaccgggttggttttgat 
qmm_CD31 attcctcaggctcgggtcttc ccgccttctgtcacctccttt 
qmm_Cdh5/VE-cadherin gcccagccctacgaacctaaa gggtgaagttgctgtcctcgt 
qmm_Cldn5 tgtcgtgcgtggtgcagagt tgctacccgtgccttaactgg 
qmm_Ctnnb1/β-catenin gagcacatcaggacacccaac gttgtgaacgtcccgagcaag 
qmm_Evi/Wls ccgtgacatggaggaagcaa ggtaacccagggaaacatcca 
qmm_Fzd1 tgtcccttgcccagtgtcttt tttagcctctcccaacccaca 
qmm_Fzd2 cccgacggctctatgttcttc cgcaatgtaggccactgacac 
qmm_Fzd3 cgtggcctgaagatatggagtg cgtgcagaaaggaatagccaag 
qmm_Fzd4 tcggctacaacgtgaccaaga tggcacataaaccgaacaaagg 
qmm_Fzd5 ctcttctgctgctgttgctgg ggcatgtgcgtcaggttgtag 
qmm_Fzd6 tcacctgggagatgacatggtt caacccagaagaccgcagaga 
qmm_Fzd7 ctacctgggctaccgcttcct cagcacagcactgaccacaca 
qmm_Gpr124 caccatcaccttgctcttgagc agattgctcctcaggtccaact 
qmm_Ndp gccaatgtgacagagggacag caaggccagagcaggatagg 
qmm_Tspan12 acaagggtagaagaagcggtca accgttccacagtatcccagca 
qmm_Wnt4 ggcgtagccttctcacagtcc acgccagcacgtctttacctc 
qmm_Wnt5a tctccttcgcccaggttgtt cctgtcttcgcaccttctcca 
qmm_Wnt5b gctgctgactgacgccaact gcactctctgatgcccgtctt 
qmm_Wnt6 gaggctgcggagacgatgtg agagcgcaggaacccgaaag 
qmm_Wnt7a cgccaaggtcttcgtggatg cggcctcgttgtatttgtcct 
qmm_Wnt7b tttctcgtcgctttgtggatg gcctgacacaccgtgacactt 
qmm_Wnt9a gccagtaccagttccgctttg cggcagaagagatggcgtaga  
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permeabilization-saturation buffer (5% BSA in PBS with 0.1% Triton). 
Primary antibodies (for detail see table Table 1) were incubated over-
night at 4 ◦C in 0.5% BSA in PBS 0.1% Triton, and secondary antibodies 
for 2 h at RT. Following nuclear staining with DAPI, slides were mounted 
with Fluoromount-G (#00− 4958-02, Invitrogen, Germany).  
Vessel fragment staining started after fixation in 4% para-
formaldehyde (PFA) with subsequent quick PBS washes and 
permeabilization-saturation as presented above. Mouse anti-desmin, rat 
anti-CD31 and rabbit anti-AQP4 dilutions are presented in Table 1. 
Images were acquired using a Nikon C1si or Nikon A1RHD25 Confocal 
Laser Scanning Microscope Systems, together with NIS Elements Mi-
croscope Imaging Software (Nikon Instruments, Inc., Düsseldorf, 
Germany). 
To assess junction protein localization and expression, images were 
taken with the 60x objective with a 1.5x electronic zoom from 3 animals 
of each age and genotype. Two independent researchers evaluated the 
blinded images with the scoring system depicted in Fig. S5A. 
2.6. Immunohistochemical staining and quantification on vibratome 
sections 
For quantitative analysis of vasculature network, pericyte and 
astrocyte coverage as well as neuronal activation, mice were anes-
thetized and then transcardially perfused with PBS for 2− 3 min to 
remove blood from vessels. The brains were dissected and post-fixed 
overnight in 4% PFA. Serial 50 μm coronal sections were cut on a VT 
1000S Leica Vibratome (Leica Biosystems GmbH, Germany). In order to 
detect endothelial cells, pericytes, astrocyte endfeet and activated neu-
rons, rat anti-CD31 (if not injected with tomato lectin), goat anti-CD13, 
rabbit anti-Aqp4 and rabbit anti-c-fos antibodies were used, respec-
tively. Free-floating sections were incubated for 1 h in permeabilization- 
saturation buffer (5% BSA in PBS with 0.1% Triton) before a 48 h in-
cubation with primary antibodies at 4 ◦C in 0.5% BSA in PBS 0.1% 
Triton buffer. After PBS washes, secondary antibodies were incubated 
for 2 h at RT or overnight at 4 ◦C. Following nuclear staining with DAPI, 
free-floating sections were mounted on slides with Fluoromount-G. 
Sections from different bregma levels (0.98 and -1.82 mm, Fig S3) 
were analysed and 30 μm confocal stacks from several area were taken 
with a Nikon C1si or A1RHD25 Confocal Laser Scanning Microscope 
System, using NIS Elements Microscope Imaging Software (Nikon In-
struments, Inc., Düsseldorf, Germany). 
Vascular area and branching point analyses were performed on 
maximum intensity projection of the 30 μm confocal stacks on NIS El-
ements Microscope Imaging software (Nikon). For pericyte volume and 
astrocyte endfeet coverage analyses, a threshold was set to create a bi-
nary mask of CD13 and AQP4 stainings on each z step of the 30 μm 
confocal stack. Thereafter, the generated binary surface and the known z 
step size were used to calculate the volume of the staining by the NIS 
Elements Microscope Imaging software (Nikon). These values were 
normalized to the vessel volume determined accordingly for the CD31 
staining. Significance was calculated with GraphPad Prism 6.0 software 
using a t-test. Volume/surface rendering of the Aqp4 staining was 
created with Imaris 9.0 software (Bitplane, Switzerland). 
2.7. Electron microscopy 
Animals were anesthetized and transcardially perfused with PBS for 
1 min followed by 4 min with 4% PFA in PBS. The isolated brains were 
post-fixed in 4% PFA and 2% glutaraldehyde in PBS overnight at 4 ◦C. 
The tissue was cut into small pieces and additionally post-fixed in the 
same fixative overnight, followed by incubation in 1% OsO4 for 2 h at 
RT with subsequent staining with lead citrate solution and 2% uranyl 
acetate solution at 4 ◦C overnight prior to embedding. After dehydration 
in a graded acetone series, the final polymerization in Durcupan was 
performed at 60 ◦C for 72 h. Sections were analysed using a Tecnai Spirit 
BioTWIN FEI electron microscope at 120 kV. Images were acquired with 
an Eagle 4 K CCD bottom-mount camera. For the quantification of ves-
icles, 12–19 cortical vessels of comparable size (4 μm diameter) were 
analysed for each animal (n = 3 per genotype). The total vesicles counts 
were normalized to the endothelial cytoplasm area and the abluminal 
and luminal vesicles were normalized to the length of their respective 
membrane side as depicted in Fig. 6B. Significance was calculated with 
GraphPad Prism 6.0 software using a t-test. 
2.8. Massive analysis of cDNA ends (MACE) 
2.8.1. Cell isolation and FACS sorting 
Brains of adult mice were collected individually, and subsequently 
olfactory bulbs, cerebellum, hindbrain and choroid plexus were 
removed, and forbrains were rolled on sterile Whatman paper to remove 
meninges. Two brains from the same genotype were pooled and 
immediately stored on ice in buffer A (Czupalla et al., 2014). They were 
subsequently homogenized in the same buffer using a dounce homoge-
nizer and centrifuged at 400 g for 10 min at 4 ◦C. Following myelin 
removal by 25% BSA centrifugation as described in MBMV isolation, the 
pellet was resuspended in buffer A and cells were filtered through a 70 
μm mesh to remove the bigger undigested vessels or tissue clamps. The 
suspension containing isolated cells and small vessels fragments was 
digested again with Collagenase/Dispase (#10269638001, Roche) and 
DNase I (#LS006333, Worthington) solution for 15 min at 37 ◦C, under 
gentle agitation. After Red blood cell lysis (#11814389001, Roche), cell 
suspension was stained with anti-CD31 antibody conjugated to PE-Cy7 
(#25− 0311-81, clone 390, Biolegend) diluted 1:100 in FACS buffer 
(5% serum in PBS). Before sorting, DAPI was added for live cell gating 
and cells were sorted and collected directly in RLTplus buffer using a 
FACSAria flow cytometer equipped with Diva Software (BD Bioscience, 
Germany). RLTplus samples were stored at − 80 ◦C until RNA isolation 
was performed according to manufacturer’s recommendation. 
2.8.2. Transcriptome profiling by MACE-Seq 
Preparation and next-generation sequencing of MACE-Seq libraries 
was performed using the “MACE-Seq kit v2.0′′ (GenXPro GmbH, 
Frankfurt, Germany) according to the supplier’s manual. 
In general the procedure follows a modified protocol described in 
Nold-Petry et al. (Nold-Petry et al., 2015). In short, 15 ng of DNase 
treated RNA per sample were used for library preparation. cDNA was 
produced by oligo dT priming and then was sheared to an average size of 
200 bp. Fragments were ligated to “TrueQuant” unique molecular 
identifiers included in the kit. MACE-Seq tags were amplified with 13 
PCR cycles and the libraries were sequenced on an Illumina NextSeq 500 
sequencer. 
2.8.3. Bioinformatics analysis of MACE-Seq data 
A total of ~28 million MACE-Seq sequencing reads were obtained 
from the two cDNA sequencing libraries. All PCR duplicated reads 
identified by the TrueQuant technology were excluded from the raw 
data sets. The remaining reads were further qualitatively trimmed, and 
the poly (A)-tail was clipped off. Filtered reads were aligned to the Mus 
musculus reference genome (GRCm38.p5) using the bowtie2 mapping 
tool (Langmead and Salzberg, 2012). The GRCm38.p5 Ensembl anno-
tation GTF file was imported into the htseq-count annotation tool to 
annotate bam files. Next, normalization of gene count data followed by 
differential gene expression analysis between the samples was per-
formed using the DEGseq R/Bioconductor package (Wang et al., 2019). 
The following thresholds were chosen for significantly differentially 
expressed genes: raw expression ≥ 20 reads, 0.5 ≤ log2fold change ≥
− 0.5, p-value ≤ 0.05. Gene Ontology enrichment analysis was per-
formed using g:Profiler (https://biit.cs.ut.ee/gprofiler/gost). Volcano 
plots were created using GraphPad Prism software, while visualization 
of most relevant GO classes was performed using GOPlot library (R, 
Bioconductor, (Walter et al., 2015)). 
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2.9. Primary cell isolation and culture 
Primary astrocytes were isolated as described by Uliasz et al. from 
pups aged between 2 and 4 days and were cultured on poly-L-lysine 
coated cell culture plates in DMEM-Glutamax medium containing 10% 
FCS and 1% penicillin-streptomycin (Uliasz et al., 2012). 
A modified protocol was utilized to isolate endothelial cells for in 
vitro cell culture experiments (Liebner et al., 2008; Paganetti et al., 
2014). Briefly, meninges-free brains from adult mice were pooled and 
homogenized as described above followed by digesting the pellet with 
collagenase II (0.75%, C2− 28, Biochrom) in buffer A (1:1:1 vol ratio) for 
1 h with shaking at 37 ◦C. For the removal of myelin, samples were 
resuspended in 25% BSA/PBS and centrifuged at 2000 g for 20 min at 4 
◦C followed by enzymatic digestion of the pellet with Collagenase/Dis-
pase (#10269638001, Roche) and DNase I (#LS006333, Worthington) 
in buffer A for 15 min at 37 ◦C. After centrifugation, cells were resus-
pended in MCDB-131 complete medium according to Czupalla et al. 
(Czupalla et al., 2014) with slight modifications (MCDB-131-based 
growth medium containing 20% FCS, 2 mM L-glutamine, 1% 
penicillin-streptomycin, 1% homemade ECGS, 5 mM heparin, 1 mM 
sodium bicarbonate), and seeded on six-well plates pre-coated with type 
1 collagen (150 μg/cm2, #344236, Corning). After 6 h, the medium was 
changed to puromycin-containing medium (4 μg/mL, #P9620, 
Sigma-Aldrich) to select for brain ECs (Devraj et al., 2016; Liebner et al., 
2008). After 2 days, the medium was changed back to puromycin-free 
medium. Following passages were cultured in the same medium if not 
specified otherwise but with fibronectin coating of the plates/inserts 
(1:100 dilution, #F1141, Sigma-Aldrich). Porcine brain microvascular 
endothelial cells (PBMEC) were isolated and cultivated the same way 
except that the collagenase II stock solution was 0.25%. 
For Wnt3a treatment, primary mouse brain microvascular ECs 
(MBMECs) were seeded on 24 well plates (2.5*104 cells/cm2) in com-
plete MCDB-131, containing 150 ng/mL mouse recombinant Wnt3a 
(#315− 20, Peprotech) or 0.1% BSA as a control. After 3, 6 and 9 days of 
culture, with the medium replaced every 3 days, the cells were washed 
twice with cold PBS, and collected in RLTplus lysis buffer for RNA 
analysis. For GSK3β inhibition treatment PBMECs were seeded on 6 
wells plates and upon confluency were treated for 24 h with 2.5μM Bio-X 
or DMSO (0.15%) as control. At the end of the treatment, cells were 
washed several times with ice-cold PBS and collected in urea/SDS sol-
ubilization buffer (2.3 M urea, 1.5% SDS, 50 mM Tris, 25 mM TCEP and 
0.01% BPB; 1.5 h at 30 ◦C) for further protein analysis. 
2.10. Impedance measurement 
Transendothelial electrical resistance (TEER) and capacitance (Ccl) 
measurements were performed in a cellZscope® device (nanoAnalytics, 
Münster, Germany) with MBMECs (105cells/cm2) seeded on the top of 
24-well filter inserts (PET ThinCerts™, 1.0 μm pore size, 2 × 106 pore 
density, Greiner Bio One, Germany) in presence or absence of primary 
astrocytes seeded on the bottom part of the same insert. Analysis of 
TEER and Ccl data was monitored and recorded until values reached a 
plateau phase (36–72 h). Each experimental condition within a set, 
consisting of the same preparation of MBMECs and the respective 
coculture with primary ACs from EviΔAC and EviCtrl pups, were carried 
out in quadruplicates (n = 4) in MBMECs culture medium. Data was 
monitored and analysed in the provided cellZscope® software (version 
1.5.3). For further information see also Paolinelli et al. (Czupalla et al., 
2014; Paolinelli et al., 2013). Significance was calculated with Graph-
Pad Prism 6.0 software using a 2way ANOVA with a Sidak’s multiple 
comparison test. At the end of the experiment, inserts were either used 
for in vitro permeability assays, for RNA isolation (2 inserts pooled) or 
fixed with ice-cold methanol (3 min) for staining as described in detail in 
Czupalla et al. (Czupalla et al., 2014). 
2.11. In vitro permeability assay 
Fluorescently labelled tracers 0.45 kD Lucifer yellow (LY, #L0144, 
Sigma-Aldrich), 3 kD Texas Red® Dextran (TXR 3 kD, #D3328, Ther-
mofischer), 20 kD tetramethylrhodamine isothiocyanate dextran (TMR 
20 kD, #73766, Sigma-Aldrich) in a final concentration of 10 μM and 70 
kD Fluorescein isothiocyanate dextran (FITC 70 kD, 5μM, #FD70S, 
Sigma-Aldrich) were added to the top chamber of the filter inserts pre-
viously used for impedance measurement. Samples were taken from the 
bottom chamber after 1 and 3 h of incubation at 37 ◦C. Fluorescence was 
analysed using the following order of excitation/emission (nm): TXR 
595/625, TMR 550/580, FITC 490/520, LY 425/525. Permeability flux 
was calculated as a ratio of bottom to top chamber fluorescence (R = B/ 
T) (Czupalla et al., 2014). Co-culture with AC KO for Evi results are 
expressed as percentage of the paired co-culture with AC control. At 
least 3 inserts per condition were used for each experimental set. Sig-
nificance was calculated with GraphPad Prism 6.0 software using a 
2way ANOVA with a Sidak’s multiple comparison test. 
2.12. Immunofluorescence on MBMECs co-culture with astrocytes 
Staining procedure was the same as described above for cryosections. 
Mouse anti-Cldn5, rabbit anti-Cav-1, goat anti-Cdh5 and corresponding 
secondary antibodies were used according to the dilution in Table 2. 
Images were taken with a Nikon C1si confocal microscope and were 
processed and analysed with NIS Elements AR Imaging Software (Nikon, 
Düsseldorf, Germany). 
2.13. Western Blot analysis 
MBMEC, PBMEC or MBMV samples in HES buffer were thawed, 
sonicated and solubilized in SB buffer (2.3 M urea, 1.5% SDS, 15 mM 
Tris, 500 mM TCEP and 0.01% BPB) for 1 h at 30 ◦C. Electrophoresis and 
transfer were performed by standard submerged method followed by 
western blotting. Primary and secondary antibodies were diluted in 
Roti-block (#A151, Roth) and incubated overnight at 4 ◦C and 1 h at RT, 
respectively (for reference detail see Table 3). Blots were visualized 
utilizing an Odyssey FC digital imaging system (LI− COR Biosciences) 
and quantitation was performed using Image Studio software (version 
2.1.10). Protein levels were normalized to β-actin/Actb. 
2.14. Statistical analysis 
Results are shown as mean ± SEM. Statistical significance was 
calculated with Prism version 6.0; GraphPad Software. Statistical anal-
ysis was performed as indicated in each material and method section. P- 
values <0.05 were considered significant (**** <00.001; *** 0.001 to 
0.001; ** 0.001 to 0.01; * 0.01 to 0.05). 
Table 3 
Antibodies for western blot analysis.  
Antibody Company Catalog # Dilution 
Abcb1a/Pgp (C219) Thermo Fisher MA1− 26528 1:500 
Actb Santa Cruz sc99879 1:1000 
Caveolin-1 BD Transduction 610,057 1:1000 
Cdh5/VE-Cadherin Santa Cruz sc6458 1:500 
Cldn5 Thermo Fisher 34− 1600 1:200 
Slc2a1/Glut1 Rabbit C-ter, see (Devraj et al., 2011) 1:2000 
Goat α-rabbit 800 LI-COR 926− 32211 1:2000 
Goat α-mouse 680 LI-COR 926− 68070 1:2000 
Donkey α-mouse IgM 650 Thermo Fisher SA5− 10153 1/2000 
Donkey α-mouse IgG 680 LI-COR 926− 68072 1/2000 
Donkey α-goat 800 LI-COR 926− 32214 1/2000  
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3. Results 
3.1. EviΔAC mice are viable and show mild brain oedema and BBB 
impairment 
In order to understand if AC-derived Wnt growth factors may 
contribute to the maintenance of endothelial BBB characteristics at the 
NVU, we initially tested and confirmed the expression of Wnt family 
members in freshly isolated and passaged ACs in vitro (Fig. S1). As ex-
pected, several Wnt ligands were detected including Wnt7a and Wnt7b 
that are known to be crucial for developmental brain angiogenesis and 
barrier formation (Fig. S1A, F). Moreover, ACs express the non- 
canonical Wnt ligands Wnt4, Wnt5a and Wnt11. In comparison to 
ECs, ACs express higher amounts of most of the Wnt genes tested by 
qPCR with exception of Wnt6 (Fig. S1F). Astrocytes also express several 
frizzled (Fzd) receptors, Lrp5/6 as well as Wnt inhibitors from the sol-
uble frizzled-related proteins (Sfrp) family (Fig. S1B-D, G). In addition to 
the expression of Wnt growth factors, receptors and other Wnt pathway- 
related genes, ACs express the non-Wnt-related Fzd ligand Ndp that can 
activate β-catenin transcriptional activity via an alternative receptor 
complex including Gpr124 and Tspan12 (Fig. S1H). 
To achieve constitutive, genetic ablation of Evi specifically in ACs we 
crossed the hGFAP-Cre (Bajenaru et al., 2002) with the Eviflox/flox mouse 
line (Carpenter et al., 2010). Global AC-specific Cre activity and 
recombination was confirmed by crossing the hGFAP-Cre to the 
ROSA26-mTmG reporter line (Muzumdar et al., 2007), suggesting a 
homogeneous recombination throughout the CNS (Fig. S2A). Although 
we could not directly detect recombination by staining for Evi due to the 
lack of suitable antibodies, we confirmed the astrocytic recombination 
in the EviΔAC CNS tissue by the co-localization of GFAP (astrocyte 
intracellular protein) with β-galactosidase, which is expressed in parallel 
to the Cre-recombinase downstream of an IRES site (Fig. S2B) (Bajenaru 
et al., 2002). 
Cre-expressing, Eviflox/flox homozygous mice (EviΔAC) were born in 
the expected Mendelian ratio (Fig. 1A), were viable and did not show 
any gross morphological and behavioural deficits (data not shown). 
Nevertheless, Evi expression in freshly isolated ACs was diminished by 
roughly 90%, suggesting successful deletion in the majority of ACs 
(Fig. 1B). In order to understand if the vascular system, and the NVU in 
particular, is morphologically and functionally affected by astrocytic 
deletion of Evi, we firstly analysed vascular density (measured as 
vascular area fraction in thick sections) and branching in young and 
middle-aged adults of 10 and 40 weeks, respectively (Fig. S3). This 
analysis was carried out for different brain regions such as the cortex, 
subcortical regions, hippocampus, thalamus and others (see Fig. S3I, J), 
to be able to determine effects related to specific brain areas. We did not 
observe an altered vascularized area fraction between EviΔAC and EviCtrl 
mice neither at 10 weeks, nor at 40 weeks of age (Fig. S3A, C, E, G). 
Along this line, we also analysed vascular branching, which did not 
show significant differences at both ages (Fig. S3B, D, F, H). This sug-
gests that the ablation of astrocytic Wnt growth factor release does not 
affect postnatal angiogenesis and vascular remodelling, resulting in a 
normal vascular network in the adult. 
To investigate the functional integrity of the BBB, we firstly char-
acterized the water content in the tissue, as a surrogate marker for brain 
oedema. Brain mass from mature adult (10–20 weeks) EviΔAC and EviCtrl 
mice was measured before and after drying of the tissue to calculate the 
wet/dry weight ratio. The brain weight/body weight (%) of the wet 
mass of the brains did not significantly differ (Fig. 1C). Comparison of 
the entire brain, including cortex, subcortical areas, cerebellum and 
hindbrain revealed a significant increase in water content in the EviΔAC 
mice (Fig. 1D). By separating the cortex and subcortical regions from the 
cerebellum and hindbrain in this analysis, it turned out that increased 
water content was restricted to the cortex/subcortical regions, whereas 
the cerebellum/hindbrain did not significantly differ (Fig. 1E, F). We did 
not observe differences between male and female mice regarding the 
water content (data not shown). In vivo permeability assays confirmed 
this finding in the spinal cord and cortex for the small molecular tracer 
fluorescein-5-thiosemicarbazide (FTSC, 0.42 kDa), whereas for the 
slightly bigger tracer TMR-dextran (3 kDa) also the cerebellum showed a 
significantly higher extravasation in the EviΔAC mice (Fig. 1G, H, I). As 
expected, organs harbouring leaky blood vessels like the kidneys or the 
liver, which served as a positive control, did not reveal any differences in 
extravasation between EviCtrl and EviΔAC mice (Fig. 1 H, I and not 
shown). In addition to the quantitative analysis of the total extravasated 
tracer in the supernatant of the homogenized brain, we qualitatively 
analysed tracer extravasation via IF microscopy upon intravenously 
injected Alexa Fluor® 555 Cadaverine (~1 kDa; A555-Cad), which was 
allowed to circulate for 5 min prior to sacrification of the animal. 
Qualitative analysis revealed increased leakage of A555-Cad in EviΔAC 
mice compared to EviCtrl mice at 10- (data not shown) and 40-weeks of 
age, evidenced by the accumulation of the tracer in cortical neurons 
(Fig. 1J). 
3.2. Wnt and BBB-related genes are downregulated in brain vessels of 
EviΔAC mice 
Next, we wanted to understand if the Wnt pathway, as well as BBB- 
related genes, were affected by Evi ablation in ACs at the NVU. To this 
end, we harvested mouse brain microvessels (MBMVs) from young adult 
(10 weeks) as well as from middle-aged adult (40 w) mice, isolated the 
RNA and analysed gene expression by quantitative real-time PCR (qRT- 
PCR). It should be noted that the isolated MBMVs contain ECs, PCs and 
AC end-feet that is documented by the staining for CD31, desmin and 
aquaporin-4 (Aqp4), respectively (Fig. 2A right panel). The Wnt/β-cat-
enin target gene Axin2, as well as Ndp were not differentially expressed 
in MBMVs of 10-week-old EviΔAC mice, whereas the Wnt/β-catenin 
target Nkd1, a negative feedback regulator of the pathway, was signif-
icantly downregulated (Fig. 2B left panel). In MBMVs of 40-week-old 
EviΔAC mice both Axin2 and Nkd1 turned out to be significantly 
downregulated, suggesting that β-catenin signalling is persistently and 
substantially affected at the NVU (Fig. 2B right panel). Given the sig-
nificant increase in water content and tracer permeability of EviΔAC 
mice, we further analysed the expression of junctional genes by qRT- 
PCR. Although we observed a trend for downregulation of several 
junctional genes like Cdh5/VE-Cadherin, Cldn5, Occln and Tjp1/ZO-1 in 
10-week-old EviΔAC mice, none of them were significantly reduced on 
the mRNA level (Fig. 2C left panel). Interestingly, Ctnnb1 expression did 
not present any alteration between the conditions in 10-week-old mice 
(Fig. 2C left panel). The general lower expression of junction genes in 
EviΔAC mice was also true for 40-week-old mice, showing a significant 
downregulation of Cdh5 and Tjp1 (Fig. 2C right panel). The down-
regulation of Cdh5 could also be confirmed by western blot analysis, 
showing a reduced protein expression by densitometric analysis in ly-
sates from MBMVs of 10-week-old EviΔAC compared to EviCtrl mice 
(Fig. S4). Cldn5 showed in trend a downregulation also on the protein 
level, which however was not significant (Fig. S4). 
To investigate the distribution and localization of junctional proteins 
at the BBB, we specifically evaluated Cdh5 and Cldn5 by immunofluo-
rescence staining and site-directed analysis of junctional organization of 
these proteins in 10- and 40-week-old mice. The detailed quantitative 
analysis of staining showed no obvious differences for the two junction 
molecules with regard to intensity, continuity and pattern in cortical 
vessels, as well as in other regions of the brain (Fig. 3A, B, Fig. S5). 
Moreover, electron microscopy analysis revealed that EviΔAC mice show 
now obvious structural alterations of cortical, inter-endothelial junc-
tions (Fig. 3C). 
The expression of BBB-associated transporters like Abcb1a/P-gp, 
Abcg2, and Slc2a1/Glut1, was not significantly regulated in MBMVs at 
both time points analysed (Fig. 2D). Glut1 did not show a differential 
expression or distribution in immunofluorescent staining (Fig. S4 C). 
Given that for vascular and BBB integrity the extracellular matrix 
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Fig. 1. Evi deletion in astrocytes induces mild 
oedema and alters BBB permeability. 
(A) Constitutive deletion of Evi in ACs follows a 
mendelian repartition (n = 284♂, 302♀). (B) Evi 
expression is reduced by 90% in cultivated ACs (pas-
sage 1) isolated form P3− 5 pups (n = 6). (C) Analysis 
of the brain/body ratio of EviΔAC animals compared to 
EviCtrl (n = 20 and 16 respectively). (D) Analysis of 
the wet/dry weight ratio in the total brain of EviΔAC 
mice. (E) wet/dry weight ratio for cortex, (F) and the 
cerebellum + hindbrain. (G) Scheme of in vivo tracer 
permeability assay. (H, I) Quantitative analysis of 
extravasated FTSC 0.45 kDa and Texas Red 3 kD 
tracers upon intravenous injection by fluorescence 
measurement of brain homogenate supernatants from 
10-20-week-old mice (n = 5–6). (J) Qualitative 
microscopic analysis of Alexa555-cadaverin extrava-
sation in 50 μm vibratome brain sections of 40-week- 
old mice (representative images of n = 3).   
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Fig. 2. Wnt targets and some junction 
genes are down regulated in vessels frag-
ments from EviΔAC animals at different age. 
(A) Vessel fragments were isolated from the 
cerebrum part of the brain of 10- and 40- 
week-old mice and subjected to qRT-PCR 
analysis. It has to be noted that these frag-
ments contain EC, PC and AC end-feet as 
shown by CD31, Desmin and AQP4 staining 
on the right panel. (B) Analysis of the Wnt 
pathway genes Axin2, Nkd1 and Ndp. (C) 
Analysis of junctional genes Cdh5, Cldn5, 
Occl, Tjp1 and Ctnnb1. (D) Analysis of the 
transporter genes Abcb1a, Slc2a1 and 
Abcg2. For each age and genotype n = 3 
mice.   
S. Guérit et al.                                                                                                                                                                                                                                   
Progress in Neurobiology 199 (2021) 101937
9
composition of the basement membrane (BM) plays a crucial role, we 
have stained for collagen IV (Fig. 3A), laminin α2 (Lama2; parenchymal, 
astrocytic BM), laminin α4 (Lama4; vascular constitutive) and laminin 
α5 (Lama5; vascular differentially regulated) (Fig. S6). However, we 
could not identify differences in expression and/or localization of these 
BM markers in 10- and 40-week-old mice. 
3.3. Cortical endothelial cells of EviΔAC mice exhibit an “activated” 
phenotype evidenced by RNA-Seq analysis 
In order to investigate the effects of astrocytic Evi deletion on cortical 
ECs in an unbiased fashion, we performed next generation sequencing 
by 3′-poly A tail based Massive Analysis of cDNA Ends (MACE) of RNA 
isolated form ECs that were FACS-sorted against CD31 from young adult 
mice (Fig. S7A, B). A total of 8103 annotated RNAs were expressed, of 
which 958 were up and 236 were down regulated between EviCtrl and 
EviΔAC cortical ECs with more than 20 raw reads per annotated gene and 
log2FC higher than 0.5 in absolute value. In order to qualitatively 
evaluate the cellular identity of the RNA subjected for MACE analysis, 
we analysed the reads for marker genes of the NVU according to 
commonly used markers and the cell specific gene expression identified 
by single cell RNA-Seq by Vanlandewijck as well as Zhang and col-
leagues (Vanlandewijck et al., 2018; Zhang et al., 2014). We could only 
detect minimal contamination by ACs and PCs that are anatomically 
closely attached cell types at the NVU (Fig. 4A). Gene ontology (GO) 
enrichment analysis revealed that the canonical Wnt pathway was 
significantly regulated, whereas the non-canonical Wnt pathway did not 
show a significant regulation in isolated brain EC from EviΔAC, sug-
gesting that Evi deletion in ACs predominantly affects canonical Wnt 
growth factors acting on the vascular endothelium (Fig. 4B, C, D). 
Moreover, the establishment of the endothelial barrier GO term was 
significantly upregulated in EviΔAC cortical ECs (Fig. 4E). Interestingly, 
we could not confirm the downregulation of junctional genes. Surpris-
ingly, Cdh5 showed a slight but significant upregulation in the RNA-Seq 
data set, whereas Cldn5 was not regulated. In line with the GO regula-
tion for barrier establishment, GOs for vascular development, adherens 
junctions (Fig. S7C), endothelial cell differentiation (Fig. S7G), extra-
cellular matrix (Fig. S7H) as well as for caveolae (Fig. 4F) showed a 
significant regulation, suggesting that cortical ECs in EviΔAC mice are in 
an “activated state” (Fig. S7). 
Notably, caveolin-1 (Cav-1), as well as Cav-2, which are part of the 
canonical Wnt pathway and crucial components of the caveolae ma-
chinery, were upregulated in cortical ECs of EviΔAC mice. This may 
suggest an increased transcytotic activity in EviΔAC animals. 
3.4. Astrocytes from EviΔAC mice support high resistance in TEER 
measurements but promote transcellular permeability of tracers in a BBB 
co-culture model in vitro 
In order to test the hypothesis of increased endothelial transcytosis 
and to further investigate the junctional contribution to vessel perme-
ability in EviΔAC mice, we made use of a well-established in vitro co- 
culture model, in which ACs have been proven to promote endothelial 
barrier function (Haseloff et al., 2005). In order to understand if Wnt 
growth factors derived from ACs play a role in this in vitro co-culture 
paradigm of the BBB, we isolated ACs from EviCtrl and EviΔAC pups 
and subjected them at passage 1 (P1) to co-culture with primary mouse 
brain microvascular endothelial cells (MBMECs) on transwell® filters 
(Fig. 5A). The Trans Endothelial Electrical Resistance (TEER) as well as 
the capacitance (Ccl) were continuously measured using the cellZ-
scope® device. We could confirm previous reports that control ACs lead 
to increased and stabilized TEER values in MBMECs compared to 
mono-cultures (Fig. 5B). Conversely, Ccl values were considerably lower 
in the co-culture with control ACs compared to the MBMEC alone 
(Fig. 5C). This corresponds to a tighter alignment and better flattening of 
ECs, which are characteristics of the brain endothelium. Surprisingly, 
Fig. 3. Junction markers do not seem affected in EviΔAC animals. 
(A–B) Immunohistochemistry on 10 μm cryosections of cortex tissue from 40- 
week-old mice for Cdh5 (A, green) collagen IV (white) as vessel marker, and 
Cldn5 (B, magenta) with tomato lectin (white) as vessel marker. (C) Trans-
mission electron microscopy of tight junctions between cortical brain endo-
thelial cells from both EviCtrl and EviΔAC animals. Representative picture of n 
= 3. 
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co-culture of MBMECs with EviΔAC ACs did not reduce TEER values in a 
paired analysis with co-cultures of MBMECs and EviCtrl ACs, but rather 
tend to be slightly increased (Fig. 5B). The Ccl values instead were 
comparable (Fig. 5C). In line with these observations, we did not find 
differences in junctional staining for Cldn5 between EviCtrl and EviΔAC 
AC co-culture, whereas compared to MBMECs alone the co-culture with 
ACs resulted in a more pronounced junctional localization of Cldn5, as 
indicated by lower Ccl values (Fig. 5C, D). Opposed to this, the mRNA 
expression of Ocln but not Cldn5 was significantly decreased in the 
co-cultures compared to the mono-culture, whereas Cdh5 expression 
was comparable to MBMECs alone (Fig. 5E). Similarly, the expression of 
the Wnt target gene Axin2 did not significantly differ between the 
conditions, although in trend the co-culture with EviCtrl ACs showed the 
highest value, indicative of higher Wnt stimulation, which in the 
co-culture with EviΔAC ACs was almost at the level of the EC 
mono-culture (Fig. 5F). 
In order to clarify if the increased brain water content and tracer 
permeability observed in EviΔAC mice in vivo may result from augmented 
transcellular transport rather than from junctional opening, we analysed 
cortical microvessels by electron microscopy for vesicle formation and 
transcytotic activity. In 10-week-old mice, no significant difference of 
vesicle formation could be identified (data not shown). However, in 40- 
week-old mice we observed an increase of vesicles in cortical micro-
vascular ECs from EviΔAC mice (Fig. 6A). To quantitatively characterize 
Fig. 4. MACE analysis on FACS isolated ECs. 
(A) Mean reads for markers of EC, AC, PC, blood cells, oligodendrocytes and neurons confirm the low contamination of other cell types in the isolated brain ECs (from 
2 young animals pooled for each genotype). (B) GO Circle plot for BBB- and Wnt-relevant GO terms, representing up or down regulated genes in EviΔAC brain ECs 
compared to EviCtrl. (C–F) Volcano plots of single GO term including genes belonging to (C) Wnt canonical pathway, (D) Wnt non-canonical pathway, (E) estab-
lishment of endothelial barrier (F) and caveolae groups. Red dots represent significantly regulated genes, green dots indicate significantly regulated genes belonging 
to both Wnt canonical pathway and vascular development and blue dots highlight unregulated genes investigated in this study. 
Fig. 5. Transendothelial electrical resistance and capacitance of brain ECs is not affected by coculture with ACs from EviΔAC. 
(A) Schematic of the in vitro BBB model using co-culture of ACs and MBMECs in direct contact via a porous membrane. (B) Transendothelial electrical resistance 
(TEER) and (C) capacitance (Ccl) of the endothelial monolayer in mono-culture and co-culture with ACs from EviCtrl or EviΔAC mice (n = 4). (D). Representative 
immunocytochemistry on cell culture inserts for junction protein Cldn5. (E–F) qPCR analysis of junction markers (E) and the Wnt target gene Axin2 (F) in EC 
cultivated with AC from EviCtrl or EviΔAC. EC culture alone is used as reference, * significant compared to EC alone, n = 5 except for Cldn5 for which n = 4. 
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Fig. 6. Increased endothelial vesicles at the BBB of EviΔAC mice. 
(A) Electron microscopy images depicting the endothelial vesicles in cortical ECs of 40-week-old EviCtrl and EviΔAC animals and (B) High resolution image of 
endothelial vesicles in EviΔAC mice and schematic representation of measurements for quantification. Red dashed line, luminal membrane length; red shape, luminal 
vesicles; blue shape, cytoplasmic vesicles; green shape, abluminal vesicles; green dashed line, abluminal membrane length. (C) Quantification of total vesicles 
performed on 12–19 4 μm diameter vessels analysed per animal and normalized to the endothelial cytoplasmic area, n = 3. (D) Quantification of luminal vesicle 
numbers performed on 12–19 images per animal and normalized to the endothelial membrane length, n = 3. (E) Quantification of abluminal vesicle numbers 
performed on 12–19 images per animal and normalized to the endothelial membrane length, n = 3. (F) Representative immunocytochemistry on cell culture inserts 
for Caveolin 1 (green). Cdh5 (red) is used to reveal cell-cell junctions. (G) In vitro permeability assay using the experimental setup presented in Fig. 5A and analysed 
after 3 h of incubation, n = 5. (H–I) qPCR analysis of the Wnt target genes Axin2 (H) and the vesicle marker Caveolin-1 (I) in EC monolayers treated with Wnt3a (w) or 
control medium (c) during 3; 6 or 9 days. (J) Western blot for Cav-1 upon Wnt/β-catenin activation by GSK3β inhibition with Bio-X (2.5μM, 24 h) in PBMECs (n = 3). 
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vesicle distribution, we analysed total, luminal and abluminal vesicles 
(Fig. 6B). Although there was a trend of an increased total as well as of 
luminal vesicles number in the EviΔAC mice, the differences were not 
significant (Fig. 6C, D). However, abluminal vesicles were significantly 
increased in number, suggesting an intensified vesicle activity in brain 
ECs of EviΔAC mice (Fig. 6E). As suggested by the MACE-Seq analysis, 
caveolae-mediated vesicular transport-related genes were increased in 
EviΔAC mice compared to controls (Fig. 4F). In line with this, in the co- 
culture paradigm, an increase in Cav-1 staining, similar to the mono- 
culture condition, was observed in EC co-culture with ACs from Evi-
ΔAC mice (Fig. 6F). Interestingly, permeability assays with differently 
sized tracers, ranging from 0.45–70 kDa performed at the experimental 
endpoint on the same inserts of the TEER measurement, revealed no 
difference between the EviCtrl and EviΔAC AC co-cultures after 1 h in-
cubation (data not shown). However, after 3 h of incubation, co-cultures 
with EviΔAC ACs showed a significantly increased permeability for 70 
kDa dextran, whereas smaller tracers revealed only a similar trend 
(Fig. 6G). These data suggest that also in vitro an increase in endothelial 
transcellular permeability in EviΔAC mice could be recapitulated by the 
MBMEC and AC co-culture model of the BBB. 
In order to investigate if Cav-1 is directly regulated downstream of 
the Wnt/β-catenin pathway, we performed a time series of recombinant 
Wnt3a (150 ng/mL) applications on MBMECs and analysed by qRT-PCR 
the regulation of Axin2 and Cav-1 at 3, 6 and 9 days of stimulation. 
Robust Axin2 upregulation at all three time points confirmed activation 
of β-catenin transcriptional activity upon Wnt3a treatment (Fig. 6H). 
Along with the duration of the culture of MBMECs, Cav-1 expression 
increased from 3 to 9 days in the control condition, whereas Cav-1 levels 
were significantly lower in the Wnt3a-treated cells at 9 days of culture 
(Fig. 6I). Due to the limited availability of MBMECs, we performed a 
comparable experiment in primary porcine brain microvascular endo-
thelial cells (PBMECs) that can be grown in large quantities. PBMECs 
were treated with 2.5μM of the GSK3 inhibitor BIO-X for 24 h, leading to 
β-catenin stabilization. Total protein was isolated from PBMECs and 
subjected to western blot analysis, revealing significantly down-
regulated Cav-1 upon GSK3 inhibition, hence β-catenin transcriptional 
activity (Fig. 6J). 
3.5. Astrocytic end-feet but not pericytes are affected in EviΔAC mice 
showing altered morphology and Aqp4 distribution 
As release of Wnt growth factors from ACs is abolished in our model, 
we systematically analysed the composition and morphology of the 
cellular compartments of the NVU. Pericytes were shown to have major 
functions in controlling BBB integrity and their ablation from the NVU 
results in increased vesicular transport across brain microvascular ECs, 
as well as in abnormal polarization of astrocytic end-feet and ACs 
detachment (Armulik et al., 2010; Daneman et al., 2010). 
Consequently, we first analysed the coverage of brain microvessels 
by CD13-positive PCs in young (10 weeks) and middle-aged (40 weeks) 
adult EviΔAC and EviCtrl mice (Fig. S8A). Interestingly, PC coverage of 
cortical brain microvessels, evidenced as percent PC volume of CD31+
vessel volume, was not significantly affected at either age in EviΔAC 
mice. A comparable observation was made for the other brain regions 
analysed (Fig. S8B, C, F, G). Instead, when the pericyte number was 
analysed by counting the PC cell bodies normalized to the vessel volume, 
it became apparent, that specifically in 10-week-old EviΔAC mice the 
number was lower than in EviCtrl (Fig. S8D, E). In 40-week-old mice, in 
most brain areas the PC cell numbers were on the same level in EviΔAC 
and EviCtrl mice (Fig. S8H, I). It is of note that at 10 w, EviCtrl mice 
showed a significantly higher level of PC cells attached to blood vessels 
than at 40 w, which might suggest that the PC numbers regress during 
ageing in the controls, whereas in the EviΔAC mice the relative PC cell 
number per vessel remains virtually unchanged between 10- and 40- 
week-old mice. 
We further analysed the coverage of brain microvessels by astrocytic 
end-feet via staining of the astrocytic water channel aquaporin-4 (Aqp4), 
which is a structural component of the end-foot membrane (Nagelhus 
et al., 2004) (Fig. 7). Analysis of the Aqp4 staining volume, normalized 
to the vessel volume evidenced by CD31 staining, revealed that in 40 w 
mice Aqp4 was significantly increased in cortical and SVZ vessels 
(Fig. 7A, C). To a lesser extent this effect was already observed as a trend 
in 10 w animals in cortical vessels only (Fig. 7B). 
Moreover, detailed analysis of the cortical vessels showed that Aqp4 
staining resulted in more background and diffuse labelling appearance 
in the EviΔAC mice (Fig. 7A). Specifically, the structure of the staining 
was not smooth along the vessel wall as in the EviCtrl mice but showed 
dotted areas around the vessel outline that are highlighted by the vol-
ume rendering of high magnification images (Fig. 7D, arrowheads). 
To better understand the morphological consequences of the changes 
observed in Aqp4, we subjected cortical brain tissue of EviΔAC and EviCtrl 
mice to electron microscopic analysis. In young adult animals (10 
weeks), alterations of astrocyte endfeet were already detectable, but less 
frequently observed in EviΔAC mice compared to controls (data not 
shown). In middle-aged (40 weeks) mice, swollen astrocytic end-feet 
were frequently detected by electron microscopy, supporting the 
initial observation of increased brain water content due to cytotoxic 
oedema as well as Aqp4 mislocalization (Fig. 7E). 
Interestingly, ACs isolated from EviΔAC mice showed significantly 
lower expression levels of the Wnt/β-catenin target genes Axin2 and 
Nkd1, suggesting that the deletion of Wnt factor release from astrocytes 
affects autocrine stimulation (Fig. 7F and G). It is of note that the 
expression of the non-Wnt-related ligand Ndp remained stable in ACs, 
suggesting that Evi deletion does not lead to a compensatory upregu-
lation of Ndp (Fig. 7H). 
3.6. EviΔAC mice show elevated neuronal activity in the lateral septal 
nucleus, indicative for physiological downstream effects of augmented BBB 
permeability in vivo 
In order to understand if the moderate brain oedema and the increase 
in transcellular permeability as well as astrocyte end-feet swelling in 
EviΔAC mice may result in altered neuronal function, we analysed the 
brains of EviΔAC and EviCtrl mice for c-fos reactivity by immunohisto-
chemistry (Fig. 8). By screening of the brains at the two different 
sectioning levels related to bregma, we observed a trend of increased 
nuclear c-fos staining in neurons of the lateral septal nucleus (LSN) of 
EviΔAC mice at 10 weeks-of-age, which was significantly increased in 40- 
week-old mice (Fig. 8A top, B, D). Although the relative c-fos reactivity 
appeared to be decreased with age, the difference between EviΔAC and 
control mice was particularly strong in the 40-week-old group, sug-
gesting that the age-related increased in permeability correlated with an 
alteration of neuronal activity in the LSN. Additionally, and only in 40- 
week old animals, neuronal activation was also increased in the peri-
ventricular thalamus (PVT) and the intermedio-dorsal thalamic nucleus 
(IMD) (Fig. 8A bottom, C, E). Although EviΔAC mice are viable and have 
no gross morphological and behavioural deficits, the slight brain 
oedema and overall increased transcellular permeability of ECs might 
lead to a modulation neural activity, potentially resulting in discrete/ 
subtle behaviour modifications later in life of these animals. 
4. Discussion 
Astrocytes (ACs), an essential cellular component of the neuro-
vascular unit (NVU). They have been shown to support the formation 
and integrity of endothelial barrier function known as the blood-brain 
barrier (BBB). The intimate connection between cells at the NVU is 
important for their communication via signalling pathways relevant for 
BBB formation and maintenance. The Wnt/β-catenin pathway, mediated 
in particular by the ligands Wnt7a/7b, is accepted to be crucial for brain 
angiogenesis, as well as for barriergenesis and BBB maintenance 
(Blanchette and Daneman, 2015; Daneman et al., 2009; Liebner et al., 
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Fig. 7. Astrocyte endfeet volume is increased in 
EviΔAC animals. 
(A) Representative pictures of cortical vessels 
(CD31, magenta) in 50 μm sections covered by 
astrocyte end-feet (AQP4, green) in of 40-week-old 
EviCtrl and EviΔAC animals (B–C) Quantification of 
AQP4 volume in different regions at bregma 0.98 
mm for (B) 10-week and (C) 40-week-old EviCtrl 
and EviΔAC animals, n = 3. (D) Volume rendering of 
confocal microscopy of the AQP4 staining around 
vessels. White arrowheads point to mis-localised 
Aqp4 in EviΔAC animals. (E) Transmission elec-
tron microscopy of astrocyte endfeet in cortex of 
40-week-old EviΔAC animals. Representative image 
of n = 3. (F–H) qPCR analysis of the Wnt target 
genes (F) Axin2, (G) Nkd1 and (H) Ndp in ACs 
isolated from EviCtrl and EviΔAC animals. Primary 
AC culture passage 1, n = 6.   
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2008; Stenman et al., 2008; Vanhollebeke et al., 2015; Zhou et al., 
2014b). Given that the potential cellular sources for Wnt growth factors 
in the established NVU of adult mammalian organisms are limited and 
that conclusive data are missing (Cheslow and Alvarez, 2016), we have 
addressed the question if AC-derived Wnt growth factors contribute to 
BBB maintenance in adult mice. 
In the present manuscript we show that Wnt growth factors released 
by ACs are required for BBB maintenance and structural integrity of AC 
end-feet at the NVU. We inactivated Wnt secretion specifically in ACs via 
hGFAP-Cre-mediated deletion of the eveness interrupted (Evi) gene, that 
is mandatory for the release of all Wnt growth factors (Bänziger et al., 
2006). Deletion of the Evi gene in the majority of ACs (Fig. 1B and S2) in 
EviΔAC mice did not lead to prominent vascular alterations, cerebral 
bleeding or a lethal phenotype, suggesting that the function of 
AC-derived Wnts could largely be compensated. However, at adult 
stages, the AC-specific Evi knock out led to a) an increased brain water 
content and tracer extravasation, as well as reduced PCs counts at ves-
sels in young adult mice (10 weeks), b) a reduction in Wnt pathway 
Fig. 8. Neuronal activation is increased in EviΔAC animals. 
(A) Representative images of activated neurons (c-fos, green) and vessels (CD31, red) stained in 10 μm sections for LSN and PVT + IMD regions of 40 w old EviCtrl and 
EviΔAC mice. (B–E) Quantification of c-fos positive cells in different regions of the brain for (B–C) 10-week and (D–E) 40-week-old animals, n = 3. (F) Schematic view 
of the modifications observed in EviΔAC compared to EviCtrl animals. 
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target gene expression in ECs and ACs (10 and 40 weeks), c) an increased 
endothelial vesicular abundance in middle-aged adult mice (40 weeks), 
d) AC end-feet swelling with mis-localised Aqp4 (40 weeks), and e) 
increased neuronal activation in the LSN, the PVT and the IMD (40 
weeks). These findings were not gender-specific when we separated 
permeability results for male and female (data not shown). Although for 
a clear-cut statement a detailed and dedicated gender analysis would be 
required. Taken together, these data consistently suggest that in the 
adult the release of Wnt growth factors from ACs is required to maintain 
the integrity of the NVU and of astrocytic end-feet in particular. 
4.1. Specificity of hGFAP-Cre-mediated recombination for mouse brain 
astrocytes 
Although GFAP is first detectable around 9.5dpc, its robust expres-
sion is detected in the mouse brain from 15.5dpc to birth coinciding with 
the differentiation of astrocytes (Fox et al., 2004; Morita et al., 1997). 
Therefore, the earlier expression of GFAP is related to other cell types, in 
particular to radial glia and neural precursor cells (Briona et al., 2015; 
Casper and McCarthy, 2006). Moreover, it has been shown for a com-
parable hGFAP-GFP line that the human GFAP promoter presents 
regional heterogeneity regarding its activity in the mouse brain (Moon 
et al., 2011). Consequently, hGFAP-mediated deletion of Evi likely takes 
place also in other cell types and may not be induced in all ACs homo-
geneously. However, at least in the zebrafish it has been shown for the 
hypothalamic region that Wnt signalling in radial glia and neural stem 
and precursor cells is not required for their proliferation and differen-
tiation (Duncan et al., 2016). As we have not observed any gross 
morphological alterations in the EviΔAC mice, we came to the conclusion 
that the hGFAP-Cre:Evifl/fl mouse model mainly affects the differentia-
tion and function of astrocytes. Still, it is possible that the EviΔAC mice 
might exhibit some defects in other cell types and brain regions that we 
did not investigate. Additionally, the observation that the BBB pheno-
type aggravated with age might be related to increased GFAP expression 
in ACs during ageing, which has been shown for the hippocampus of 
control and senescence-accelerated-prone mice (Wu et al., 2005). 
Therefore, adult neurogenesis in the subventricular zone (SVZ) (Garcia 
et al., 2004), ageing-related defects (Wu et al., 2005) or conditions of 
regeneration after injury (Briona et al., 2015), for which GFAP expres-
sion and Wnt/β-catenin signalling have been described might be inter-
esting to analyse in the future. 
4.2. Astrocytic contribution to barrier signals in adult mice 
During embryonic vascularization of the neuroectoderm, when 
endothelial Wnt signalling is prominent, the growth factors Wnt7a and 
Wnt7b are known to be released by neural precursor cells (NPCs), 
inducing specific endothelial β-catenin transcriptional activation 
(Blanchette and Daneman, 2015; Eubelen et al., 2018; Reis and Liebner, 
2013; Zhou and Nathans, 2014). In parallel, Ndp, a factor unrelated to 
Wnts, is also able to activate β-catenin transcription which however, 
appears to be specific for the cerebellum and the retina as part of the 
CNS (Junge et al., 2009; Ye et al., 2009). Although it has been shown 
that the Wnt pathway is instrumental in maintaining endothelial BBB 
function in the adult mammalian and teleost brain, the source of Wnt 
growth factors remains elusive (Zhou and Nathans, 2014). With the 
rapid decline in NPCs during postnatal stages, barrier-maintaining sig-
nals are likely to be released from other cell types. While pericytes (PCs) 
are crucial for BBB integrity (Armulik et al., 2010; Daneman et al., 
2010), a recent single cell sequencing study on the molecular identity of 
brain vascular cells suggests that PCs and smooth muscle cells (SMCs) 
neither express Wnt7a/7b, nor Ndp (Vanlandewijck et al., 2018). 
Instead, the main source of Wnts and Ndp are ACs with minor contri-
bution from the newly described vascular fibroblast-like cells. Astro-
cytes start to differentiate from neural precursor cells at late gestation 
stages in the mouse, in a process that persists for several weeks, up to one 
month after birth (Bayraktar et al., 2015; Qian et al., 2000). We could 
confirm broad expression of Wnt growth factors by ACs compared to 
whole brain or MBMECs mRNA by quantitative RT-PCR (Fig. S1). What 
became also apparent in the RT-PCR analyses is that ACs express the 
entire receptor and co-receptor machinery allowing them to respond to 
Wnt signals potentially in an autocrine manner. Moreover, ACs also 
express sonic hedgehog (Shh) as well as angiopoietin-1 (Ang-1) that 
have been shown to contribute to BBB integrity and stability under 
chronic inflammatory conditions (data not shown) (Alvarez et al., 2011; 
Gurnik et al., 2016). 
Recombination of ACs by hGFAP-driven Cre activity (Fig. S2) results 
in an almost complete knock out of Evi, as evidenced by ~90% down- 
regulation of its mRNA in cultured cortical ACs (Fig. 1B). As suggested 
by the analysis of isolated cortical capillary fragments, Wnt/β-catenin 
pathway activation is indeed suppressed in the neurovascular unit 
indicated by the significant downregulation of the Wnt target genes 
Axin2 and Nkd1 in 40-week-old mice (Fig. 2B). While Glut-1, as another 
canonical Wnt target, appears to be upregulated on the mRNA level in 
FACS-sorted ECs by MACE-Seq analysis, we could not detect differences 
in protein expression and/or distribution (Figure S4C). 
Here we show that interfering with Wnt growth factor release from 
ACs, by conditional deletion of Evi in GFAP-expressing cells, is not 
compensated by significant changes in the expression of other BBB- 
promoting growth factors such as Ndp (Fig. 7H). 
4.3. Wnt release from ACs has only little impact on EC junctions 
Given the increase in brain water content and in brain permeability 
upon Evi deletion in ACs, we initially interpreted this as an opening of 
BBB junctions, ultimately leading to a mild brain oedema and tracer 
leakage, respectively (Fig. 1C-J). Indeed, mRNA expression of VE- 
cadherin (Cdh5) as well as ZO-1 were down-regulated in MBMVs from 
middle-aged (40 weeks) EviΔAC mice, supporting the interpretation that 
junctions are affected to some extent by Evi deletion in ACs (Fig. 2C). 
Instead, RNA-Seq from FACS-isolated ECs, revealed an “activated” 
angiogenic-like expression profile with no obvious downregulation of 
tight junction genes (Fig. 4E). Specifically, Cdh5 turned out to be 
upregulated in CD31+ FACS-sorted ECs, which, at first glance, might be 
contradictory to the MBMV results. However, it could be in line with 
previous reports, showing increased Cdh5 expression in immature brain 
ECs that becomes reduced during BBB maturation (Breier et al., 1996). 
Moreover, the differences in the isolation procedure for MBMVs and 
CD31+ ECs by FACS-sorting may explain the discrepancies of individual 
gene regulation. 
Further analysis of regulated genes by western blotting confirmed a 
significant downregulation of Cdh5 in the vessel fragments (Fig. S4A). 
However, qualitative and quantitative analyses of Cdh5, Cldn5 (Fig. 3 
and S5), as well as ZO-1 (data not shown) localization in brain did not 
reveal apparent differences between EviΔAC and EviCtrl mice. In vitro 
experiments also supported the interpretation that the abrogation of the 
Wnt release from ACs has only minor effects on inter-endothelial junc-
tions. Indeed, co-cultures of MBMECs with ACs derived from EviΔAC and 
EviCtrl mice did not lead to different expression and/or localization of 
junctional proteins such as Cdh5 or Cldn5 (Fig. 5D, E and 6 F). More-
over, TEER measurement, which is a marker for junctional tightness, 
revealed a trend of increased resistance values in MBMECs co-cultured 
with ACs from EviΔAC mice compared to controls (Fig. 5B). This sug-
gests that over all the junctional effects are minor and may not explain 
the increased permeability in EviΔAC mice. Along with this observation it 
is of note that although the Wnt target Axin2 was in trend decreased, it 
was not significantly diminished in MBMECs co-cultured with EviΔAC. In 
this regard, the prime suspect for functional compensation of para-
cellular barrier maintenance could still be Ndp, which is released by ACs 
even in the absence of Evi and is able to activate endothelial β-catenin 
(Junge et al., 2009; Ye et al., 2009). Our data however support the hy-
pothesis that Ndp might not rescue the entire spectrum of functions of 
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Wnt signalling in EviΔAC mice, given the fact that knock out animals 
develop brain oedema and increased transcellular transport (Fig. 1). 
In this regard it is important to note that previous publications by us 
and others demonstrated the role of β-catenin-mediated Wnt signalling 
specifically in CNS ECs, by endothelial gain- or loss-of-function models. 
The same is true for publications revealing the receptor involvement for 
Wnt pathway activation in ECs (Benz et al., 2019; Daneman et al., 2009; 
Liebner et al., 2008; Posokhova et al., 2015; Stenman et al., 2008; 
Vanhollebeke et al., 2015; Zhou and Nathans, 2014; Zhou et al., 2014a). 
In the present study we abolished the secretion of Wnts by the deletion of 
the Evi gene in the ACs only. Therefore, the milder phenotype observed 
in EviΔAC mice compared to previous approaches, might be explained on 
the one hand by an incomplete knock out of about 10% (Fig. 1B) and on 
the other hand by the possibility that other cells of the NVU may take 
over Wnt or Ndp secretion. 
Moreover, in EviΔAC animals, not only secretion of canonical Wnts is 
affected, but also of non-canonical ligands which are known to activate 
the planar cell polarity (PCP) and Ca2+ signalling pathways. Interest-
ingly, canonical and non-canonical Wnts can exert opposing effect in 
various cells and organism, which may contribute to the overall 
phenotype we observed in EviΔAC mice (Lezzerini and Budovskaya, 
2014; Sato et al., 2010). 
4.4. ECs show an activated expression profile and increased transcellular 
transport 
As the oedema and permeability phenotypes could not be explained 
by junction disruption, we isolated MBMECs from cortex of adult EviCtrl 
and EviΔAC by flow cytometry to have a broader insight in transcription 
profile alterations. By the MACE transcriptional profiling it became 
apparent that brain ECs from EviΔAC exhibit an angiogenic-like profile 
compared to those of EviCtrl (Fig. 4 and S7). Although endothelial dif-
ferentiation genes as well as several ECM genes like Lama5 turned out to 
be upregulated in the EviΔAC mice, staining for Lama5 did not corrob-
orate this on the level of protein distribution in cortical sections of 10- 
and 40-week-old mice (Fig. S6). Moreover, the angiogenic-like gene 
profile did not coincide with increased vascular density and branching in 
various brain regions (Fig. S3). However, the transcriptomic analysis 
further revealed a group of regulated genes related to caveolae (Fig. 4F). 
Interestingly, we observed an increase in vesicle numbers in cortical 
brain ECs of middle-aged (40 week) EviΔAC animals (Fig. 6A-E). In line 
with the in vivo observation, MBMECs presented reduced Cav1 staining 
upon coculture with EviCtrl ACs, which was not visible in case of EviΔAC 
ACs (Fig. 6F). The latter finding coincided with an increased perme-
ability to high molecular weight tracers (Fig. 6G). Additionally, we 
provide evidence for an inhibitory function of the Wnt/β-catenin 
pathway on the expression of Cav-1. MBMECs were stimulated in vitro 
for 9 days with recombinant Wnt3a or PBMECs were stimulated with 
BIO-X for 24 h, demonstrating reduced expression of Cav-1 upon Wnt 
pathway activation (Fig. 6H-J). Similarly, it has been shown in experi-
mental autoimmune encephalomyelitis (EAE), a mouse model for mul-
tiple sclerosis, that inactivation of Wnt/β-catenin signalling exacerbates 
the clinical presentation of mice by increasing Cav-1-mediated trans-
cellular transport (Lengfeld et al., 2017). In line with this, Cav-1 can 
inhibit Wnt/β-catenin signalling by sequestering β-catenin at caveolae 
membrane domains in 3T3 cells (Galbiati et al., 2000). Instead, domi-
nant activation of Wnt/β-catenin signalling in ECs diminishes vesicular 
transport and Cav-1 expression in leaky vessels of the circumventricular 
organs (Benz et al., 2019; Y. Wang et al., 2019). On the other hand, a 
certain amount of Cav-1 might also be required for proper Wnt signal-
ling and consequently for BBB maintenance, as activation of the 
Wnt/β-catenin pathway via internalization of Lrp6 requires expression 
of Cav-1 in non-endothelial cells (Yamamoto et al., 2006). In the light of 
these published data, our work supports the interpretation that in adult 
mice, Wnt factors secreted by ACs are crucial for maintaining low 
transcellular vesicular traffic by limiting Cav-1 expression in brain ECs 
to a physiological state. In the absence of Wnt ligand availability, as in 
the EviΔAC condition, upregulated Cav-1 cannot support 
Fzd/Lrp-mediated signalling but might exclusively mediate vesicula-
tion, thereby increasing BBB transcellular permeability. 
The increase in trans-endothelial transport likely also mediates the 
increased tracer permeability and mild oedema formation in the Evi- 
deficient mice. In this regard it has been reported that the Major Facil-
itator Superfamily Domain Containing 2A (Mfsd2a) regulated vesicular 
transport in ECs of the CNS by establishing a unique lipid composition of 
the plasma membrane that inhibits vesicle formation (Andreone et al., 
2017; Ben-Zvi et al., 2014). Interestingly, the canonical Wnt pathway 
was recently shown to influence the lipid metabolism together with Myc 
in the context of hepatocellular carcinoma, in which Wnt/Myc increased 
the fraction of poly-unsaturated fatty acyl groups in a Ras-dependent 
manner (Yao et al., 2018). Although we could not identify an altered 
regulation of Mfsd2a expression in EviΔAC mice (data not shown), it will 
be interesting to address the interaction of Wnt and lipid metabolism in 
brain ECs in future investigations. 
4.5. PC coverage and astrocyte end-feet integrity is impaired in EviΔAC 
mice, leading to altered neuronal activity 
It is worth noting that the NVU is composed of at least five or six cell 
types - if fibroblast-like cells are included - all of which might be influ-
enced by the deletion of Evi in ACs. Isolated MBMVs that were used in 
the present work contained at least 3 cell types including ECs, PCs, and 
AC end-feet. Consequently, the downregulation of Wnt targets observed 
in qRT-PCR analysis (Fig. 2B) might be derived from other cells than 
ECs. This interpretation is supported by the finding that isolated ACs 
from EviΔAC mice also showed a down-regulation of the tested Wnt 
targets (Fig. 7F, G). Furthermore, astrocytic end-feet integrity became 
severely impaired upon the persistent lack of Wnt factor release from 
ACs in 40-week-old mice. Specifically, Aqp4 showed a broader area 
around the vessels, which is in line with its delocalization, as well as 
with end-feet swelling, and signs of disintegration evidenced by electron 
microscopy (Fig. 7A-E). Regarding the AC end-feet phenotype, it has 
been shown that AQP4 promotes cytotoxic oedema formation in case of 
water intoxication (Manley et al., 2000). Therefore, these data could 
explain the oedema and astrocyte end-feet swelling we observed in our 
experimental model. However, AQP4 also has protective effects in case 
of vasogenic oedema and may reduce oedema-associated epileptic 
events (Bloch and Manley, 2007). How the AC-specific deletion of Evi 
might influence the outcome of the diseased brain like in stroke, will be 
subject to future investigations. 
In young adults (10 weeks), reduced PC numbers at vessels appear to 
precede the AC end-feet phenotype (Fig. S8). Given that in middle-aged 
mice, no major differences in PCs could be observed, we concluded that 
PC coverage might be affected only during early postnatal maturation of 
brain vessels, potentially contributing to increased permeability that we 
observed in young adult (10 weeks) EviΔAC mice. This interpretation fits 
to observations made in PC-deficient mice, in which the lack of PCs leads 
to increased tracer permeability in ECs, mediated by elevated trans-
cytosis (Armulik et al., 2010). In turn, PC-deficient mice also develop an 
AC end-feet phenotype, similar to the one we described in EviΔAC mice, 
hence opening the possibility that AC-PC interaction may in part be 
controlled by AC-derived Wnt factors. 
Ultimately, our findings may support the interpretation that the end- 
feet phenotype in astrocytes results from the reciprocal interactions 
between the cells of the NVU specifically, between ECs, PCs and ACs. 
Moreover, ACs may require autocrine Wnt signals to maintain end-feet 
integrity and consequently support BBB function in ECs at the NVU. 
This interpretation is supported by the observation that ACs express 
almost the entire set of frizzled receptors and Lrp co-receptors (Fig. S1) 
and that the Wnt target gene Axin2 and Nkd1 were downregulated in 
ACs from EviΔAC mice in vitro (Fig. 7F and G). 
Finally, we observed increased c-fos reactivity in the lateral septal 
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nucleus (LSN) in 40-week-old EviΔAC animals, although spontaneous 
mouse behaviour was not altered (Fig. 8). The LSN region takes part in 
the regulation of processes linked to social behaviour, especially to 
anxiety and stress (Kim and Han, 2016; Mesic et al., 2015; Talishinsky 
and Rosen, 2012). Moreover, in middle-aged mice (40 weeks), two 
nuclei of the thalamus (PVT and IMD) also exhibit enhanced c-fos 
reactivity in EviΔAC mice. Defined by their projections to different brain 
areas, these regions were shown to affect fear-related memory and 
alcohol/drug addiction among others (Gupta et al., 2018; Mátyás et al., 
2014; Paydar et al., 2014; Penzo et al., 2015). Therefore, it would be 
interesting to test in future studies if the stress and fear response is 
modified in EviΔAC mice. Moreover, these findings might be also rele-
vant for understanding the crosstalk between vessels and neurons in 
general, given the recently published work by Chow and colleagues, 
showing that Cav-1 in brain arterioles is required for neurovascular 
coupling (Chow et al., 2020). 
5. Conclusion 
In this study, we show by inhibiting the release of Wnt growth factors 
from astrocytes (ACs) via the cell-specific deletion of the Evi gene in 
mice (EviΔAC), that AC-derived Wnts are required to maintain the 
integrity of the neurovascular unit (NVU) and consequently of endo-
thelial blood-brain barrier (BBB) function. EviΔAC mice exhibit a pro-
gressive loss of endothelial barrier properties, evidenced by increased 
tracer permeability and oedema formation in adults. We observe that 
brain ECs of EviΔAC mice show increased expression of Cav-1 and 
significantly augmented vesicular abundance, but no detectable changes 
in junctional integrity. We further demonstrate that during ageing of 
EviΔAC mice, an initial decrease in pericyte number (10 w) at brain 
vessels is followed by astrocytic end-feet alterations with mis- 
localisation of the water channel Aqp4, concomitant with a loss of 
end-feet structural integrity. Therefore, ACs might require - like previ-
ously shown for ECs (Zhou et al., 2014b) - sustained, low level autocrine 
Wnt/β-catenin signalling to maintain structural and functional integrity 
of the NVU and ultimately to maintain the physiological condition of the 
BBB. 
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2019. Low wnt/β-catenin signaling determines leaky vessels in the subfornical organ 
and affects water homeostasis in mice. Elife 8, 204. https://doi.org/10.7554/ 
eLife.43818. 
Ben-Zvi, A., Lacoste, B., Kur, E., Andreone, B.J., Mayshar, Y., Yan, H., Gu, C., 2014. 
Mfsd2a is critical for the formation and function of the blood–brain barrier. Nature 
1–18. https://doi.org/10.1038/nature13324. 
Blanchette, M., Daneman, R., 2015. Formation and maintenance of the BBB. Mech. Dev. 
138, 8–16. https://doi.org/10.1016/j.mod.2015.07.007. Pt 1.  
Bloch, O., Manley, G.T., 2007. The role of aquaporin-4 in cerebral water transport and 
edema. Neurosurg. Focus 22, E3. 
Breier, G., Breviario, F., Caveda, L., Berthier, R., Schnurch, H., Gotsch, U., Vestweber, D., 
Risau, W., Dejana, E., 1996. Molecular cloning and expression of murine vascular 
endothelial-cadherin in early stage development of cardiovascular system. Blood 87, 
630–641. 
Briona, L.K., Poulain, F.E., Mosimann, C., Dorsky, R.I., 2015. Wnt/ß-catenin signaling is 
required for radial glial neurogenesis following spinal cord injury. Dev. Biol. (Basel) 
403, 15–21. https://doi.org/10.1016/j.ydbio.2015.03.025. 
Carpenter, A.C., Rao, S., Wells, J.M., Campbell, K., Lang, R.A., 2010. Generation of mice 
with a conditional null allele for Wntless. Genesis 48, 554–558. https://doi.org/ 
10.1002/dvg.20651. 
Casper, K.B., McCarthy, K.D., 2006. GFAP-positive progenitor cells produce neurons and 
oligodendrocytes throughout the CNS. Mol. Cell. Neurosci. 31, 676–684. https://doi. 
org/10.1016/j.mcn.2005.12.006. 
Chang, J., Mancuso, M.R., Maier, C., Liang, X., Yuki, K., Yang, L., Kwong, J.W., Wang, J., 
Rao, V., Vallon, M., Kosinski, C., Zhang, J.J.H., Mah, A.T., Xu, L., Li, L., Gholamin, S., 
Reyes, T.F., Li, R., Kuhnert, F., Han, X., Yuan, J., Chiou, S.-H., Brettman, A.D., 
Daly, L., Corney, D.C., Cheshier, S.H., Shortliffe, L.D., Wu, X., Snyder, M., Chan, P., 
Giffard, R.G., Chang, H.Y., Andreasson, K., Kuo, C.J., 2017. Gpr124 is essential for 
blood-brain barrier integrity in central nervous system disease. Nat. Med. 23, 
450–460. https://doi.org/10.1038/nm.4309. 
Cheslow, L., Alvarez, J.I., 2016. Glial-endothelial crosstalk regulates blood–brain barrier 
function. Curr. Opin. Pharmacol. 26, 39–46. https://doi.org/10.1016/j. 
coph.2015.09.010. 
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